Cerebellum’s MetLife MET Stock Holding History

Cerebellum’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$579K	Buy	+11,351	New	+$548K	0.31%	7
2019 Q1	–	Sell	-6,182	Closed	-$254K	–	506
2018 Q4	$254K	Buy	+6,182	New	+$265K	0.18%	167

Other funds holding MET

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return

Cerebellum's MET Position: Q4 2019 in Review

Cerebellum opened a new position in MetLife (MET) in Q4 2019: 11,351 shares worth $579K. The stake represents 0.31% of the portfolio and ranks #7 among its holdings. This is a return to the name: Cerebellum previously reported a position in MET as recently as Q4 2018.

Cerebellum first reported a position in MET in Q4 2018 and has held it in 2 quarters since. 1,114 funds tracked by Wall St. Rank hold MET as of Q4 2019.

Cerebellum held 11,351 shares of MetLife worth $579K as of Q4 2019.
MetLife was a new Cerebellum position in Q4 2019.
MetLife made up 0.31% of Cerebellum's portfolio in Q4 2019, its #7 holding.
Cerebellum first reported a position in MetLife in Q4 2018 and has held it in 2 quarters since.
1,114 funds tracked by Wall St. Rank held MetLife as of Q4 2019.

Based on Cerebellum's 13F filing for Q4 2019, filed 16 Jan 2020.